Login Register Cart 0
Generic placeholder image

Current Diabetes Reviews

Editor-in-Chief

ISSN (Print): 1573-3998
ISSN (Online): 1875-6417

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Brain-derived Neurotrophic Factor Level and Gene Polymorphism as Risk Factors for Depression in Patients with type 2 Diabetes Mellitus- A Case-Controlled Study

In Press, (this is not the final "Version of Record"). Available online 08 January, 2024
Author(s): Hany Hammad, Inass Shaltout, Mai M. Fawzy, Laila A. Rashed, Noha Adel and Tarek S. Abdelaziz*
Published on: 08 January, 2024

Article ID: e080124225344

DOI: 10.2174/0115733998274778231218145449

Price: $95

Abstract

Background: Diabetes mellitus and depression are comorbidities that can be caused by each other. Brain-derived neurotrophic factor (BDNF) functions as a neuronal growth factor. It maintains the functional integrity of the nervous system.

Aim: To study the possible association between BDNF levels and gene polymorphism with depression in patients diagnosed with type 2 diabetes mellitus.

Methods: The Elisa technique measured BDNF, and rs6265 gene polymorphism was detected using real-time PCR. Depression was assessed utilizing a clinical interview tool designed to establish the diagnosis of depression and differentiate it from other psychiatric diseases.

Results: BDNF levels were significantly lower in patients with type 2 diabetes mellitus and symptoms of depression than in patients with type 2 diabetes mellitus and no symptoms of depression (82.6±16.1. Vs 122± 17.47, p˂ 0.001). There was a statistically significant difference in BDNF levels in patients with diabetes among the three genotypes of the BDNF gene (p-value < 0.001). Val/ Val carriers had the highest serum BDNF levels, and Met/ Met carriers had the lowest serum BDNF levels. Subgroup analysis showed statistically significant genotype-related differences in serum BDNF levels among the three subgroups in the Depression group. Val/ Val carriers had the highest serum BDNF levels, and Met/ Met carriers had the lowest serum BDNF levels. BDNF Val66Met polymorphism had no significant association with the presence of depression, yet there was a trend towards significance (p = 0.05)

Conclusion: In this pilot, Low levels of BDNF were associated with depression in patients with type 2 diabetes. Carriers of the Met/ Met allele have the lowest serum BDNF levels. Multicenter studies with more participants are required.

[1]
Diagnostic and statistical manual of mental disorders: DSM-5™. American Psychiatric Association. 2013.
[2]
Ghandour AA. Out of pocket expenditure on non-communicable diseases among egyptian patients. Egypt J Hosp Med 2015; 58: 55-62.
[http://dx.doi.org/10.12816/0009361]
[3]
Golden SH, Lazo M, Carnethon M, et al. Examining a bidirectional association between depressive symptoms and diabetes. JAMA 2008; 299(23): 2751-9.
[http://dx.doi.org/10.1001/jama.299.23.2751] [PMID: 18560002]
[4]
Mezuk B, Eaton WW, Albrecht S, Golden SH. Depression and type 2 diabetes over the lifespan: A meta-analysis. Diabetes Care 2008; 31(12): 2383-90.
[http://dx.doi.org/10.2337/dc08-0985] [PMID: 19033418]
[5]
Rotella F, Mannucci E. Depression as a risk factor for diabetes: A meta-analysis of longitudinal studies. J Clin Psychiatry 2013; 74(1): 31-7.
[http://dx.doi.org/10.4088/JCP.12r07922] [PMID: 23419223]
[6]
Nouwen A, Winkley K, Twisk J, et al. Type 2 diabetes mellitus as a risk factor for the onset of depression: A systematic review and meta-analysis. Diabetologia 2010; 53(12): 2480-6.
[http://dx.doi.org/10.1007/s00125-010-1874-x] [PMID: 20711716]
[7]
Aikens JE, Perkins DW, Lipton B, Piette JD. Longitudinal analysis of depressive symptoms and glycemic control in type 2 diabetes. Diabetes Care 2009; 32(7): 1177-81.
[http://dx.doi.org/10.2337/dc09-0071] [PMID: 19389814]
[8]
Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23(1): 56-62.
[http://dx.doi.org/10.1136/jnnp.23.1.56] [PMID: 14399272]
[9]
Bath KG, Lee FS. Variant BDNF (Val66Met) impact on brain structure and function. Cogn Affect Behav Neurosci 2006; 6(1): 79-85.
[http://dx.doi.org/10.3758/CABN.6.1.79] [PMID: 16869232]
[10]
Rauskolb S, Zagrebelsky M, Dreznjak A, et al. Global deprivation of brain-derived neurotrophic factor in the CNS reveals an area-specific requirement for dendritic growth. J Neurosci 2010; 30(5): 1739-49.
[http://dx.doi.org/10.1523/JNEUROSCI.5100-09.2010] [PMID: 20130183]
[11]
Pruunsild P, Kazantseva A, Aid T, Palm K, Timmusk T. Dissecting the human BDNF locus: Bidirectional transcription, complex splicing, and multiple promoters. Genomics 2007; 90(3): 397-406.
[http://dx.doi.org/10.1016/j.ygeno.2007.05.004] [PMID: 17629449]
[12]
Lima Giacobbo B, Doorduin J, Klein HC, Dierckx RAJO, Bromberg E, de Vries EFJ. Brain-derived neurotrophic factor in brain disorders: Focus on neuroinflammation. Mol Neurobiol 2019; 56(5): 3295-312.
[http://dx.doi.org/10.1007/s12035-018-1283-6] [PMID: 30117106]
[13]
Egan MF, Kojima M, Callicott JH, et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003; 112(2): 257-69.
[http://dx.doi.org/10.1016/S0092-8674(03)00035-7] [PMID: 12553913]
[14]
Sartorius A, Hellweg R, Litzke J, et al. Correlations and discrepancies between serum and brain tissue levels of neurotrophins after electroconvulsive treatment in rats. Pharmacopsychiatry 2009; 42(6): 270-6.
[http://dx.doi.org/10.1055/s-0029-1224162] [PMID: 19924587]
[15]
Shen T, You Y, Joseph C, et al. BDNF polymorphism: A review of its diagnostic and clinical relevance in neurodegenerative disorders. Aging Dis 2018; 9(3): 523-36.
[http://dx.doi.org/10.14336/AD.2017.0717] [PMID: 29896439]
[16]
Zhou JX, Li HC, Bai XJ, et al. Functional Val66Met polymorphism of Brain-derived neurotrophic factor in type 2 diabetes with depression in Han Chinese subjects. Behav Brain Funct 2013; 9(1): 34-4.
[http://dx.doi.org/10.1186/1744-9081-9-34] [PMID: 23968401]
[17]
Ventriglia M, Bocchio Chiavetto L, Benussi L, et al. Association between the BDNF 196 A/G polymorphism and sporadic Alzheimer’s disease. Mol Psychiatry 2002; 7(2): 136-7.
[http://dx.doi.org/10.1038/sj.mp.4000952] [PMID: 11840305]
[18]
Küppers E, Beyer C. Dopamine regulates brain-derived neurotrophic factor (BDNF) expression in cultured embryonic mouse striatal cells. Neuroreport 2001; 12(6): 1175-9.
[http://dx.doi.org/10.1097/00001756-200105080-00025] [PMID: 11338187]
[19]
Horch HW, Katz LC. BDNF release from single cells elicits local dendritic growth in nearby neurons. Nat Neurosci 2002; 5(11): 1177-84.
[http://dx.doi.org/10.1038/nn927] [PMID: 12368805]
[20]
Hyman C, Hofer M, Barde YA, et al. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 1991; 350(6315): 230-2.
[http://dx.doi.org/10.1038/350230a0] [PMID: 2005978]
[21]
Klein AB, Williamson R, Santini MA, et al. Blood BDNF concentrations reflect brain-tissue BDNF levels across species. Int J Neuropsychopharmacol 2011; 14(3): 347-53.
[http://dx.doi.org/10.1017/S1461145710000738] [PMID: 20604989]
[22]
American Diabetes Association. 2. Classification and diagnosis of diabetes: Standards of medical care in diabetes-2021. Diabetes Care 2021; 44(Suppl. 1): S15-33.
[http://dx.doi.org/10.2337/dc21-S002] [PMID: 33298413]
[23]
Chacon-Cortes D, Haupt LM, Lea RA, Griffiths LR. Comparison of genomic DNA extraction techniques from whole blood samples: A time, cost and quality evaluation study. Mol Biol Rep 2012; 39(5): 5961-6.
[http://dx.doi.org/10.1007/s11033-011-1408-8] [PMID: 22228086]
[24]
Chan YH. Biostatistics 103: Qualitative data - tests of independence. Singapore Med J 2003; 44(10): 498-503.
[PMID: 15024452]
[25]
Chan YH. Biostatistics 104: Correlational analysis. Singapore Med J 2003; 44(12): 614-9.
[PMID: 14770254]
[26]
Hegazi R, El-Gamal M, Abdel-Hady N, Hamdy O. Epidemiology of and risk factors for type 2 diabetes in egypt. Ann Glob Health 2016; 81(6): 814-20.
[http://dx.doi.org/10.1016/j.aogh.2015.12.011] [PMID: 27108148]
[27]
Nanayakkara N, Pease A, Ranasinha S, et al. Depression and diabetes distress in adults with type 2 diabetes: Results from the Australian National Diabetes Audit (ANDA) 2016. Sci Rep 2018; 8(1): 7846.
[http://dx.doi.org/10.1038/s41598-018-26138-5] [PMID: 29777153]
[28]
de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: A meta-analysis. Psychosom Med 2001; 63(4): 619-30.
[http://dx.doi.org/10.1097/00006842-200107000-00015] [PMID: 11485116]
[29]
Heraclides A, Chandola T, Witte DR, Brunner EJ. Psychosocial stress at work doubles the risk of type 2 diabetes in middle-aged women: Evidence from the Whitehall II study. Diabetes Care 2009; 32(12): 2230-5.
[http://dx.doi.org/10.2337/dc09-0132] [PMID: 19720842]
[30]
Lustman PJ, Clouse RE. Depression in diabetic patients: The relationship between mood and glycemic control. J Diabetes Complications 2005; 19(2): 113-22.
[PMID: 15745842]
[31]
Bădescu SV, Tătaru C, Kobylinska L, et al. The association between Diabetes mellitus and Depression. J Med Life 2016; 9(2): 120-5.
[PMID: 27453739]
[32]
Kreider KE. Diabetes distress or major depressive disorder? A practical approach to diagnosing and treating psychological comorbidities of diabetes. Diabetes Ther 2017; 8(1): 1-7.
[http://dx.doi.org/10.1007/s13300-017-0231-1] [PMID: 28160185]
[33]
Khaledi M, Haghighatdoost F, Feizi A, Aminorroaya A. The prevalence of comorbid depression in patients with type 2 diabetes: An updated systematic review and meta-analysis on huge number of observational studies. Acta Diabetol 2019; 56(6): 631-50.
[http://dx.doi.org/10.1007/s00592-019-01295-9] [PMID: 30903433]
[34]
Katon WJ, Russo JE, Heckbert SR, et al. The relationship between changes in depression symptoms and changes in health risk behaviors in patients with diabetes. Int J Geriatr Psychiatry 2010; 25(5): 466-75.
[http://dx.doi.org/10.1002/gps.2363] [PMID: 19711303]
[35]
Moulton CD, Pickup JC, Ismail K. The link between depression and diabetes: The search for shared mechanisms. Lancet Diabetes Endocrinol 2015; 3(6): 461-71.
[http://dx.doi.org/10.1016/S2213-8587(15)00134-5] [PMID: 25995124]
[36]
Mondal AC, Fatima M. Direct and indirect evidences of BDNF and NGF as key modulators in depression: Role of antidepressants treatment. Int J Neurosci 2019; 129(3): 283-96.
[http://dx.doi.org/10.1080/00207454.2018.1527328] [PMID: 30235967]
[37]
Leal G, Afonso PM, Salazar IL, Duarte CB. Regulation of hippocampal synaptic plasticity by BDNF. Brain Res 2015; 1621: 82-101.
[http://dx.doi.org/10.1016/j.brainres.2014.10.019] [PMID: 25451089]
[38]
Ozan E, Okur H, Eker Ç, Eker ÖD, Gönül AS, Akarsu N. The effect of depression, BDNF gene val66met polymorphism and gender on serum BDNF levels. Brain Res Bull 2010; 81(1): 61-5.
[http://dx.doi.org/10.1016/j.brainresbull.2009.06.022] [PMID: 19589373]
[39]
Sharif S, Raza MT, Mushtaq S, Afreen B, Hashmi BA, Ali MH. Frequency of depression in patients with type 2 diabetes mellitus and its relationship with glycemic control and diabetic microvascular complications. Cureus 2019; 11(7): e5145.
[http://dx.doi.org/10.7759/cureus.5145] [PMID: 31523573]
[40]
Gary TL, Crum RM, Cooper-Patrick L, Ford D, Brancati FL. Depressive symptoms and metabolic control in African-Americans with type 2 diabetes. Diabetes Care 2000; 23(1): 23-9.
[http://dx.doi.org/10.2337/diacare.23.1.23] [PMID: 10857963]
[41]
Wei YG, Cai DB, Liu J, et al. Cholesterol and triglyceride levels in first-episode patients with major depressive disorder: A meta-analysis of case-control studies. J Affect Disord 2020; 266: 465-72.
[http://dx.doi.org/10.1016/j.jad.2020.01.114] [PMID: 32056914]
[42]
Suwa M, Kishimoto H, Nofuji Y, et al. Serum brain-derived neurotrophic factor level is increased and associated with obesity in newly diagnosed female patients with type 2 diabetes mellitus. Metabolism 2006; 55(7): 852-7.
[http://dx.doi.org/10.1016/j.metabol.2006.02.012] [PMID: 16784955]
[43]
Li B, Lang N, Cheng ZF. Serum Levels of brain-derived neurotrophic factor are associated with diabetes risk, complications, and obesity: A cohort study from chinese patients with type 2 diabetes. Mol Neurobiol 2016; 53(8): 5492-9.
[http://dx.doi.org/10.1007/s12035-015-9461-2] [PMID: 26454822]
[44]
Sandrini L, Di Minno A, Amadio P, Ieraci A, Tremoli E, Barbieri S. Association between obesity and circulating Brain-Derived Neurotrophic Factor (BDNF) levels: Systematic review of literature and meta-analysis. Int J Mol Sci 2018; 19(8): 2281.
[http://dx.doi.org/10.3390/ijms19082281] [PMID: 30081509]
[45]
Prabu P, Poongothai S, Shanthirani CS, Anjana RM, Mohan V, Balasubramanyam M. Altered circulatory levels of miR-128, BDNF, cortisol and shortened telomeres in patients with type 2 diabetes and depression. Acta Diabetol 2020; 57(7): 799-807.
[http://dx.doi.org/10.1007/s00592-020-01486-9] [PMID: 32025863]
[46]
Youssef MM, Underwood MD, Huang YY, et al. Association of BDNF Val66Met polymorphism and brain BDNF levels with major depression and suicide. Int J Neuropsychopharmacol 2018; 21(6): 528-38.
[http://dx.doi.org/10.1093/ijnp/pyy008] [PMID: 29432620]
[47]
Pei Y, Smith AK, Wang Y, et al. The brain‐derived neurotrophic‐factor ( BDNF ) val66met polymorphism is associated with geriatric depression: A meta‐analysis. Am J Med Genet B Neuropsychiatr Genet 2012; 159B(5): 560-6.
[http://dx.doi.org/10.1002/ajmg.b.32062] [PMID: 22610920]
[48]
Yoshimura R, Kishi T, Suzuki A, et al. The brain-derived neurotrophic factor (BDNF) polymorphism Val66Met is associated with neither serum BDNF level nor response to selective serotonin reuptake inhibitors in depressed Japanese patients. Prog Neuropsychopharmacol Biol Psychiatry 2011; 35(4): 1022-5.
[http://dx.doi.org/10.1016/j.pnpbp.2011.02.009] [PMID: 21338649]
[49]
Verhagen M, van der Meij A, van Deurzen P A M, et al. Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity. Mol Psychiatry 2010; 15(3): 260-71.
[http://dx.doi.org/10.1038/mp.2008.109] [PMID: 18852698]

Rights & Permissions Print Cite
© 2025 Bentham Science Publishers | Privacy Policy